biotech
BioVisioN AG and Abbott Sign Research Agreement
Filed in archive Corporate and Industrial News by ruth on September 13, 2005
BlogPicture



German biotech company BioVisioN AG signed an agreement with Abbott to collaborate on research relating to the discovery of novel biomarkers for lung cancer. According to the agreement, BioVisioN will be paid to analyze biological samples provided by Abbott to discover tumor biomarkers, and, if successful, milestones and royalty payments.

Dr. Rainer Voegeli, Chief Business Officer of BioVisioN AG, says:
"Our early activities in the area of proteomics and peptidomics are now paying off. We are the world leader in peptide biomarker discovery with our patent protected technologies. We are proud that Abbott has chosen us as a partner."


BioVisioN AG specializes in the identification of disease-relevant peptides and proteins using Peptidomics and Differential Peptide Display. The company was founded in 1997 and today employs 45 people. Apart from research collaborations, BioVisioN provides access to its technology also in fee-for-service contracts as a Biological Research Organization.

Permalink: BioVisioN AG and Abbott Sign Research Agreement
Tags: proteomics  lung+cancer  biotech  biovision  research  research+agreement  sign+research  abbott+sign 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/9213
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for BioVisioN AG and Abbott Sign Research Agreement:

  • Currently 6.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 6.00 out of 2 vote(s) cast.
 
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!